Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales
NegativeFinancial Markets

Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales
Moderna has reported a significant loss in the third quarter, primarily due to declining sales of its Covid-19 vaccine. This shift highlights the challenges the company faces as demand for its vaccine decreases, prompting it to explore new product offerings. The situation is crucial as it reflects broader trends in the vaccine market and the ongoing impact of the pandemic on pharmaceutical companies.
— via World Pulse Now AI Editorial System




